PT75339B - Process for the preparation of n1-acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds - Google Patents

Process for the preparation of n1-acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds

Info

Publication number
PT75339B
PT75339B PT75339A PT7533982A PT75339B PT 75339 B PT75339 B PT 75339B PT 75339 A PT75339 A PT 75339A PT 7533982 A PT7533982 A PT 7533982A PT 75339 B PT75339 B PT 75339B
Authority
PT
Portugal
Prior art keywords
preparation
acyl
amino
tetrahydroquinoline compounds
compounds
Prior art date
Application number
PT75339A
Other languages
English (en)
Other versions
PT75339A (en
Original Assignee
Simes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes filed Critical Simes
Publication of PT75339A publication Critical patent/PT75339A/pt
Publication of PT75339B publication Critical patent/PT75339B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
PT75339A 1981-07-29 1982-07-28 Process for the preparation of n1-acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds PT75339B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8123213A IT1226045B (it) 1981-07-29 1981-07-29 Derivati tetraidrochinolici

Publications (2)

Publication Number Publication Date
PT75339A PT75339A (en) 1982-08-01
PT75339B true PT75339B (en) 1985-01-04

Family

ID=11204942

Family Applications (1)

Application Number Title Priority Date Filing Date
PT75339A PT75339B (en) 1981-07-29 1982-07-28 Process for the preparation of n1-acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds

Country Status (14)

Country Link
US (1) US4507307A (pt)
EP (1) EP0072070B1 (pt)
JP (1) JPS5849367A (pt)
AT (1) ATE25845T1 (pt)
AU (1) AU560656B2 (pt)
CA (1) CA1195331A (pt)
DE (1) DE3275645D1 (pt)
DK (1) DK337082A (pt)
ES (2) ES515712A0 (pt)
GR (1) GR77230B (pt)
IE (1) IE53401B1 (pt)
IT (1) IT1226045B (pt)
PT (1) PT75339B (pt)
ZA (1) ZA825427B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
US4992465A (en) * 1988-09-27 1991-02-12 Ciba-Geigy Corporation 3-amino-dihydro-(1)-benzopyrans
US6180632B1 (en) 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554737A (en) * 1949-07-22 1951-05-29 Geigy Ag J R Basically substituted tetrahydroquinoline derivatives
US2942024A (en) * 1957-09-16 1960-06-21 Du Pont Resolution of lysine
GB1111617A (en) * 1964-07-14 1968-05-01 Glaxo Lab Ltd Amides of optically active carboxylic acids and (í‚)-2-dehydroemetine or (í¬)-2-dehydroemetine
US3452026A (en) * 1966-03-15 1969-06-24 Bristol Myers Co Substituted 1,2,3,4-tetrahydroquinolines
US3389141A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-aryloxyethyltetrahydro-isoquinolines
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
NO133758C (pt) * 1970-04-04 1976-06-23 Takeda Chemical Industries Ltd
NL188407C (nl) * 1977-10-18 1992-06-16 Kessels Gerard Werkwijze voor de bereiding van d(-)-alfa-fenylglycine.

Also Published As

Publication number Publication date
DK337082A (da) 1983-01-30
EP0072070A3 (en) 1983-05-11
GR77230B (pt) 1984-09-11
ES519850A0 (es) 1984-10-01
ES8407478A1 (es) 1984-10-01
IE53401B1 (en) 1988-11-09
AU8648182A (en) 1983-02-03
AU560656B2 (en) 1987-04-16
US4507307A (en) 1985-03-26
ATE25845T1 (de) 1987-03-15
IT1226045B (it) 1990-12-10
IT8123213A0 (it) 1981-07-29
DE3275645D1 (de) 1987-04-16
IE821794L (en) 1983-01-29
CA1195331A (en) 1985-10-15
PT75339A (en) 1982-08-01
EP0072070A2 (en) 1983-02-16
ES8403458A1 (es) 1984-04-01
JPS5849367A (ja) 1983-03-23
ZA825427B (en) 1983-08-31
ES515712A0 (es) 1984-04-01
EP0072070B1 (en) 1987-03-11

Similar Documents

Publication Publication Date Title
IL67172A (en) Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,process for their preparation and pharmaceutical agents containing these compounds
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
PT74923B (en) Process for preparing 1,2-diaminocyclobutene-3,4-di ones substituted and pharmaceutical compositions therewith
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
DE3163256D1 (en) Imidazoline derivative, its salts, process for preparation and pharmaceutical compositions thereof
HRP920591B1 (en) New compounds
DE3273629D1 (en) New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
IL70199A0 (en) Substituted 6,7-dihydro-1-oxo-1h,5h-benzo(i)quinolizine-2-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
PH22782A (en) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives
DE3262919D1 (en) Imidazoline derivatives, process for the preparation thereof, pharmaceutical compositions containing them and their use
PT75339A (en) Process for the preparation of n1-acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds
EP0113880A3 (en) Derivatives from 2-azabicyclo(2.2.1)heptane, process for their preparation, agents containing them and their use, and 2-azabicyclo(2.2.1)heptane derivatives as intermediates, and process for their preparation
HUT52060A (en) Process for producing new, substituted quinoline derivatives and pharmaceutical compositions containing them
PT74400B (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
EP0074413A4 (en) URACIL COMBINATIONS, THEIR PRODUCTION PROCESS AND MEDICAL COMPOSITIONS CONTAINING THEM
DE3261303D1 (en) Process for the preparation of 4,4'-dibenzoylamino dianthrimide carbazole
ZA827576B (en) Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)-quinoline derivatives
ZA804291B (en) New imines derivatives of 1'amino-5 benzodioxole-1,3 useful for medicaments
IL66465A0 (en) 1,2-dithiol-3-ylideneammonium derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
ES8304925A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
IT1157921B (it) Composti policiclici sostituiti sull'anello a, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
PT82257A (en) Process for preparing substituted 1,8-naphthyridinones and pharmaceutical compositions containing them
DE3066040D1 (en) Process for the preparation of 4,5-dinitro-1,8-dihydroxyanthraquinone